1800-272-662
Shopping Cart 0
countryflagAU
Login

Clover Health Investments Corp

Healthcare US CLOV

2.02USD
0.03(1.51%)

Last update at 2026-03-11T20:26:00Z

Day Range

1.962.03
LowHigh

52 Week Range

0.614.71
LowHigh

Fundamentals

  • Previous Close 1.99
  • Market Cap1653.66M
  • Volume3756593
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-77.08500M
  • Revenue TTM2115.22M
  • Revenue Per Share TTM4.34
  • Gross Profit TTM 126.19M
  • Diluted EPS TTM-0.19

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -338.84400M -587.75600M -91.58200M -363.73700M -
Minority interest - - 3.90M 3.90M 3.90M
Net income -305.40100M -604.66600M -148.69000M -402.80500M -
Selling general administrative 486.64M 445.75M 191.70M 187.33M -
Selling and marketing expenses - - - - -
Gross profit 22.73M -79.18200M 82.42M 12.56M -
Reconciled depreciation 1.19M 1.25M 0.56M 0.55M -
Ebit -370.92400M -636.99200M -92.70700M -183.19900M -185.79700M
Ebitda -369.73700M -635.74600M -92.15200M -182.64800M -
Depreciation and amortization 1.19M 1.25M 0.56M 0.55M -
Non operating income net other - - - - -
Operating income -370.92400M -636.99200M -92.70700M -183.19900M -
Other operating expenses 3847.61M 2108.99M 765.60M 645.47M 0.34M
Interest expense 1.36M 16.91M 57.11M 39.07M 0.00000M
Tax provision - - - - -
Interest income - - 0.12M - -
Net interest income -1.36300M -16.91000M -57.10800M -39.06800M -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -33.44300M 16.91M 57.11M 39.07M -
Total revenue 3476.69M 1472.00M 672.89M 462.27M -
Total operating expenses 393.66M 557.81M 175.13M 195.76M -
Cost of revenue 3453.95M 1551.18M 590.47M 449.70M -
Total other income expense net 32.08M 49.24M 1.12M -180.53800M -
Discontinued operations - - - - -
Net income from continuing ops -338.84400M -587.75600M -91.58200M -363.73700M -
Net income applicable to common shares -338.84400M -587.75600M -136.39200M -363.73700M -201.92800M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 570.67M 808.62M 950.80M 267.25M 0.10M
Intangible assets 2.99M - - - -
Earning assets - - - - -
Other current assets 1.40M 24.43M 52.95M 0.30M 2.17M
Total liab 284.28M 460.88M 411.49M 835.63M 0.12M
Total stockholder equity 286.39M 347.74M 539.32M -568.38300M -0.01763M
Deferred long term liab - - - - -
Other current liab 80.57M 406.38M 175.57M 33.13M 0.12M
Common stock 0.05M 0.05M 0.05M 788.51M 0.00400M
Capital stock 0.05M 0.05M 0.05M 788.51M -
Retained earnings -2159.79400M -1955.58200M -1616.73800M -6.76247M -0.01763M
Other liab - 16.19M 14.10M 155.71M 167.96M
Good will 0.00000M - - - -
Other assets - 15.73M 950.80M -589.16816M 9.70M
Cash 122.86M 103.79M 299.97M 28.00M 0.00000M
Cash and equivalents - - - - -
Total current liabilities 261.12M 440.66M 372.62M 33.93M 0.12M
Current deferred revenue 141.69M - 165.87M - -
Net debt -118.20000M -97.93100M -272.14100M -27.19703M -
Short term debt 1.67M 1.83M 3.06M 0.81M -
Short long term debt - - - 0.81M -
Short long term debt total 4.66M 5.86M 27.83M 0.81M -
Other stockholder equity 2132.31M 1917.58M 1541.91M -1350.12917M 0.05M
Property plant equipment - 9.78M 7.65M 9.96M 13.04M
Total current assets 427.97M 625.00M 752.55M 28.30M 252.96M
Long term investments 121.00M 138.11M 175.94M - -
Net tangible assets - 327.74M 404.15M -621.32900M -492.77000M
Short term investments 119.82M 230.97M 315.29M 123.10M -
Net receivables 113.83M 147.16M 62.32M 84.94M 44.55M
Long term debt - - 19.94M - -
Inventory 70.05M -101.88400M -153.91700M - -
Accounts payable 37.18M 32.45M 28.13M 134.65M 114.84M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -2.37000M -9.37400M -1.93400M - -
Additional paid in capital - - - - -
Common stock total equity - - - 788.51M -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 10.25M 15.73M 10.43M 828.12M 0.10M
Deferred long term asset charges - - - - -
Non current assets total 142.70M 183.62M 198.26M 828.12M 0.10M
Capital lease obligations 4.66M 5.86M 7.89M - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 95.13M -434.72400M 138.10M -180.70500M 99.00M
Change to liabilities 7.63M 5.31M 10.85M 6.30M 1.26M
Total cashflows from investing activities 95.13M -435.44700M 137.40M -181.90800M 97.53M
Net borrowings - -30.92500M 1.25M 333.74M 29.76M
Total cash from financing activities -4.96200M 925.39M 858.23M 333.98M 74.59M
Change to operating activities 98.71M 196.76M -0.77400M 32.57M 46.45M
Net income -338.84400M -587.75600M -6.74484M -363.73700M -201.92800M
Change in cash -113.75500M 207.62M 28.00M -7.80500M 18.83M
Begin period cash flow 299.97M 92.35M 67.60M 75.40M -
End period cash flow 186.21M 299.97M 28.00M 67.60M 75.40M
Total cash from operating activities -203.92600M -282.32600M -2.22712M -159.87500M -153.28200M
Issuance of capital stock 1.40M 289.92M 813.62M 0.60M -
Depreciation 1.19M 1.25M 0.56M 0.55M 0.49M
Other cashflows from investing activities - - - - -
Dividends paid - 0.30M - - -
Change to inventory - - - - -
Change to account receivables -8.02900M -9.39100M -34.53000M -6.96500M -11.49000M
Sale purchase of stock -6.36200M -0.14700M - 0.00000M -
Other cashflows from financing activities 95.13M 666.85M 44.91M 343.05M -0.54100M
Change to netincome 35.39M 97.83M 20.68M 155.09M 11.93M
Capital expenditures 4.47M 0.72M 0.69M 0.02M 1.48M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 98.31M 192.67M 4.63M 32.31M -
Stock based compensation 164.31M 163.72M - 3.30M -
Other non cash items -128.88900M 13.88M -0.11725M 24.69M -
Free cash flow -208.39300M -283.04900M -2.22712M -159.89800M -

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CLOV
Clover Health Investments Corp		 0.03 1.51% 2.02 - - 0.78 4.83 0.62 -0.6496
UNH
UnitedHealth Group Incorporated		 2.91 1.03% 285.25 22.57 18.38 1.33 5.65 1.38 13.97
ELV
Elevance Health Inc		 7.11 2.52% 289.79 18.00 12.66 0.65 2.87 0.74
CVS
CVS Health Corp		 -0.6 0.79% 75.72 12.06 9.08 0.29 1.34 0.47 8.96
CI
Cigna Corp		 -1.57 0.60% 260.87 30.25 10.09 0.39 2.10 0.50

Reports Covered

Stock Research & News

View All

Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. is based in Franklin, Tennessee.

Clover Health Investments Corp

3401 Mallory Lane, Franklin, TN, United States, 37067

Key Executives

Name Title Year Born
Mr. Vivek Garipalli Co-Founder, CEO & Chairman of Directors 1979
Mr. Andrew Toy Co-Founder, Pres, & Director 1979
Ms. Jamie L. Reynoso Chief Operating Officer 1970
Mr. Prabhdeep Singh Chief Growth Officer 1985
Mr. Scott J. Leffler Chief Financial Officer 1975
Mr. Conrad Wai Chief Technology Officer NA
Mr. Derrick L. Nueman Head of Investor Relations & Corp. strategy NA
Ms. Wendy Richey Chief Compliance Officer NA
Mr. Joseph Richards Martin Gen. Counsel & Corp. Sec. 1977
Ms. Rachel Fish Chief People Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.